Cargando…

The assessment of side effects of tyrosine kinase inhibitors (TKI) applied in patients with advanced thyroid cancer (TC) - one centre experience

Detalles Bibliográficos
Autores principales:	Krajewska, Jolanta, Kukulska, Aleksandra, Paliczka-Cieślik, Ewa, Handkiewicz-Junak, Daria, Gawlik, Tomasz, Olczyk, Tomasz, Kropińska, Aleksandra, Skoczylas, Aleksander, Michalik, Barbara, Jarząb, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618014/ http://dx.doi.org/10.1186/1756-6614-6-S2-A33

Ejemplares similares

Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer – a prospective comparison of long-term outcomes
por: Kukulska, Aleksandra, et al.
Publicado: (2020)

Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma
por: Krajewska, Jolanta, et al.
Publicado: (2019)

Only peak thyroglobulin concentration on day 1 and 3 of rhTSH-aided RAI adjuvant treatment has prognostic implications in differentiated thyroid cancer
por: Ledwon, Aleksandra, et al.
Publicado: (2021)

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi
por: Kukulska, Aleksandra, et al.
Publicado: (2010)

13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study
por: Handkiewicz-Junak, Daria, et al.
Publicado: (2009)

TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma
por: Rusinek, Dagmara, et al.
Publicado: (2020)

Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival
por: Krajewska, Jolanta, et al.
Publicado: (2020)

The role of postoperative adjuvant radiotherapy in local recurrence risk in medullary thyroid carcinoma
por: Kukulska, Aleksandra, et al.
Publicado: (2019)

Stereotactic radiotherapy is a useful treatment option for patients with medullary thyroid cancer
por: Kukulska, Aleksandra, et al.
Publicado: (2021)

Comparison of clinical examination with orbital MRI evaluation in patients with thyroid orbitopathy - do we need imaging and when?
por: Król, Aleksandra, et al.
Publicado: (2013)

Lobo-isthmectomy in the management of differentiated thyroid cancer
por: Krajewska, Jolanta, et al.
Publicado: (2023)

Coexistence of TERT Promoter Mutations and the BRAF V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients
por: Rusinek, Dagmara, et al.
Publicado: (2018)

Therapeutic Strategy in Low-Risk Papillary Thyroid Carcinoma – Long-Term Results of the First Single-Center Prospective Non-Randomized Trial Between 2011 and 2015
por: Czarniecka, Agnieszka, et al.
Publicado: (2021)

Current status of the prognostic molecular markers in medullary thyroid carcinoma
por: Oczko-Wojciechowska, Malgorzata, et al.
Publicado: (2020)

The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAF(V600E) Mutation Status and Other Prognostic Factors
por: Czarniecka, Agnieszka, et al.
Publicado: (2015)

Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma—Do They Exist?
por: Szpak-Ulczok, Sylwia, et al.
Publicado: (2020)

Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours
por: Wojtas, Bartosz, et al.
Publicado: (2017)

The prognostic value of tumor markers doubling times in medullary thyroid carcinoma - preliminary report
por: Gawlik, Tomasz, et al.
Publicado: (2010)

Role of nuclear medicine imaging in differential diagnosis of accessory spleens in patients after splenectomy
por: d’Amico, Andrea, et al.
Publicado: (2012)

Factors Modifying Outcome After MIBG Therapy in Children With Neuroblastoma—A National Retrospective Study
por: Ussowicz, Marek, et al.
Publicado: (2021)

Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues
por: Pfeifer, Aleksandra, et al.
Publicado: (2013)

Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations
por: Oczko-Wojciechowska, Malgorzata, et al.
Publicado: (2017)

Corrigendum: Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations
por: Oczko-Wojciechowska, Malgorzata, et al.
Publicado: (2017)

A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping
por: Fujarewicz, Krzysztof, et al.
Publicado: (2007)

Gene signature of the post-Chernobyl papillary thyroid cancer
por: Handkiewicz-Junak, Daria, et al.
Publicado: (2016)

Sacubitril/valsartan for cardioprotection in breast cancer (MAINSTREAM): design and rationale of the randomized trial
por: Tajstra, Mateusz, et al.
Publicado: (2023)

Concentrations of Selected Adipokines, Interleukin-6, and Vitamin D in Patients with Papillary Thyroid Carcinoma in Respect to Thyroid Cancer Stages
por: Warakomski, Jakub, et al.
Publicado: (2018)

Differences in Gene-Gene Interactions in Graves’ Disease Patients Stratified by Age of Onset
por: Jurecka-Lubieniecka, Beata, et al.
Publicado: (2016)

Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?
por: Rusinek, Dagmara, et al.
Publicado: (2017)

Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers – the role of Ct serum level
por: Jarzab, Barbara, et al.
Publicado: (2013)

The Association of SNPs Located in the CDKN2B-AS1 and LPA Genes With Carotid Artery Stenosis and Atherogenic Stroke
por: Lasek-Bal, Anetta, et al.
Publicado: (2019)

Cognitive Impairment in End Stage Renal Disease Patients Undergoing Hemodialysis: Markers and Risk Factors
por: Olczyk, Piotr, et al.
Publicado: (2022)

2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?
por: Pacini, Furio, et al.
Publicado: (2021)

The Influence of Healthy Habits on Cognitive Functions in a Group of Hemodialysis Patients
por: Olczyk, Piotr, et al.
Publicado: (2023)

Safety and Feasibility of Radiation Therapy Combined with CDK 4/6 Inhibitors in the Management of Advanced Breast Cancer
por: Kubeczko, Marcin, et al.
Publicado: (2023)

Evaluation of Subclinical Hypothyroidism in Children and Adolescents: A Single-Center Study
por: Such, Kamila, et al.
Publicado: (2016)

Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide
por: Kos-Kudła, Beata, et al.
Publicado: (2017)

Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus intercalated TKI with chemotherapy for EGFR-mutated nonsmall cell lung cancer
por: Gijtenbeek, Rolof G.P., et al.
Publicado: (2022)

(99m)Tc Labeled Glucagon-Like Peptide-1-Analogue ((99m)Tc-GLP1) Scintigraphy in the Management of Patients with Occult Insulinoma
por: Sowa-Staszczak, Anna, et al.
Publicado: (2016)

PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET
por: van Dongen, Guus A. M. S., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ae735s1np88ak3qcoags9tejf8